Page last updated: 2024-08-26

safrole oxide and Infections, Staphylococcal

safrole oxide has been researched along with Infections, Staphylococcal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aguado, JM; Aguirregabiria, M; Benítez, RM; Berbel, D; Boix-Palop, L; Calbo, E; Carratala, J; Cobo, S; Cuervo, G; Domínguez, MÁ; Euba, G; Garcia-Pais, MJ; Garcia-Pardo, G; Gasch, O; Gioia, F; Gomez-Zorrilla, S; Gomila-Grange, A; Grillo, S; Hereu, P; Horna, G; Iftimie, S; Jover-Sáenz, A; Loeches-Yagüe, MB; López-Contreras, J; López-Cortés, LE; Meije, Y; Miro, JM; Morata, L; Oriol, I; Padullés, A; Pallarés, N; Paño, JR; Pedro-Botet, ML; Pérez-Rodríguez, MT; Pujol, M; San-Juan, R; Tebe, C; Videla, S1

Trials

1 trial(s) available for safrole oxide and Infections, Staphylococcal

ArticleYear
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible
    BMJ open, 2021, 08-05, Volume: 11, Issue:8

    Topics: Adult; Bacteremia; Cloxacillin; Fosfomycin; Humans; Methicillin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Safrole; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome

2021